Serum macrophage migration inhibitory factor levels in Hashimoto's thyroiditis; A case control study

Thyroid Research

Volumn 7, Issue 1, 2014, Pages

  Ayaz, Teslime ^a   Sahin, Serap Baydur ^a   Sahin, Osman Zikrullah ^a   Cure, Medine Cumhur ^a   Sumer, Fatih ^a   Ilkkilic, Kadir ^a  

^a RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; THYROGLOBULIN; THYROID PEROXIDASE ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 84989184522     PISSN: None     EISSN: 17566614     Source Type: Journal    
DOI: 10.1186/s13044-014-0011-1     Document Type: Article

References (24)

1. Dayan CM, Daniels GH: Chronic autoimmune thyroiditis. N Engl J Med 1996, 11;335(2):99-107.
2. Weetman AP: Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 2003, 148(1):1-9.
3. Ajjan RA, Watson PF, McIntosh RS, Weetman AP: Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clin Exp Immunol 1996, 105(3):523-528.
4. Grubeck-Loebenstein B, Buchan G, Chantry D, Kassal H, Londei M, Pirich K, Barrett K, Turner M, Waldhausl W, Feldmann M: Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: Thyroid follicular cells produce interleukin-1 alpha and interleukin-6. Clin Exp Immunol 1989, 77(3):324-330.
5. Calandra T, Roger T: Macrophage migration inhibitory factor: A regulator of innate immunity. Nat Rev Immunol 2003, 3(10):791-800.
6. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R: MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995, 7;377(6544):68-71.
7. Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R: An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A 1996, 23;93(15):7849-7854.
8. Gregory JL, Morand EF, McKeown SJ, Ralph JA, Hall P, Yang YH, McColl SR, Hickey MJ: Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2. J Immunol 2006, 1;177(11):8072-8079.
9. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, Bucala R: Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response. Proc Natl Acad Sci U S A 2002, 99:345-350.
10. Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J: Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 2002, 4(4):449-460.
11. Bucala R, Lolis E: Macrophage migration inhibitory factor: A critical component of autoimmune inflammatory diseases. Drug News Perspect 2005, 18(7):417-426.
12. Morand EF, Leech M, Weedon H, Metz C, Bucala R, Smith MD: Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. Rheumatology (Oxford) 2002, 41(5):558-562.
13. Becker H, Maaser C, Mickholz E, Dyong A, Domschke W, Gaubitz M: Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-Associated vasculitides. Clin Rheumatol 2006, 25(3):368-372.
14. Foote A, Briganti EM, Kipen Y, Santos L, Leech M, Morand EF: Macrophage migration inhibitory factor in systemic lupus erythematosus. J Rheumatol 2004, 31(2):268-273.
15. Zaletel K, Gaberscek S: Hashimoto's thyroiditis: from genes to the disease. Curr Genomics 2011, 12(8):576-588.
16. Chistiakov DA: Immunogenetics of Hashimoto's thyroiditis. J Autoimmune Dis 2005, 2(1):1.
17. Figueroa-Vega N, Alfonso-Pérez M, Benedicto I, Sánchez-Madrid F, González-Amaro R, Marazuela M: Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metab 2010, 95(2):953-962.
18. Zhang JA, Zhang J, Xu L, Mar H, Wu XY: Measurement of IL-12 and IL-18 in sera of patients with autoimmune thyroid disease. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2006, 22(5):630-632.
19. Guo H, Peng D, Yang XG, Wang Y, Xu BC, Ni JS, Meng W, Jiang YF: A higher frequency of circulating IL-22(+)CD4(+) T cells in Chinese patients with newly diagnosed Hashimoto's thyroiditis. PLoS One 2014, 9(1):e84545.
20. Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, Weedon H, Holdsworth SR, Bucala R, Morand EF: Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999, 42(8):1601-1608.
21. Sanchez-Zamora Y, Terrazas LI, Vilches-Flores A, Leal E, Juárez I, Whitacre C, Kithcart A, Pruitt J, Sielecki T, Satoskar AR, Rodriguez-Sosa M: Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus. FASEB J 2010, 24(7):2583-2590.
22. Bretz JD, Baker JR Jr: Apoptosis and autoimmune thyroid disease: following a TRAIL to thyroid destruction? Clin Endocrinol (Oxf ) 2001, 55(1):1-11.
23. Mackay IR: Science, medicine, and the future: Tolerance and autoimmunity. BMJ 2000, 8;321(7253):93-96.
24. Stosic-Grujicic S, Stojanovic I, Maksimovic-Ivanic D, Momcilovic M, Popadic D, Harhaji L, Miljkovic D, Metz C, Mangano K, Papaccio G, Al-Abed Y, Nicoletti F: Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus. J Cell Physiol 2008, 215(3):665-675.